Find and Pitch Jounalists, Get Your Story Covered

Tags: Coya Therapeutics Dr. Reddy's Laboratories COYA 302 Investigational Combination Therapy Amyotrophic Lateral Sclerosis

	Profile	Recent Articles on Subject
1	Judy George MedPage Today Medical reporter, writer. Medical reportingartsliterature	Brain Changes Emerge Decades Before Huntington's Diagnosis - 5 days ago Herpes and Alzheimer's Tau; Dementia and Autism; Extended Paxlovid for Long COVID - 15 days ago Alzheimer's Data Withdrawn - 2 months ago Brain Implant Helps ALS Patient Quickly Restore Conversational Communication - 5 months ago Parkinsonism in Athletes Linked With Chronic Traumatic Encephalopathy Pathology - 6 months ago ALS Therapy to Be Pulled From the Market, Drugmaker Says - 10 months ago Epstein-Barr and MS; When Lewy Pathology Starts; Alzheimer's Blood Test Assessed - 10 months ago Cognitive Decline in MS Predicted by Paramagnetic Rim Lesions - 11 months ago Alzheimer's Paper Retracted; Pets and Human Cognition; Long COVID Internal Tremors - about 1 year ago Midlife Alzheimer's Biomarker; How Measles Spread in the Brain; MS and HIV - about 1 year ago Alzheimer's Vaccines Are Back; Streamlining Prior Authorization; Rare APOE Variant - about 1 year ago Advanced Parkinson's Patient Regains Ability to Walk Confidently - about 1 year ago Biological Age Predicts Dementia; APOE4 and Tau Patterns; AI and MS Brain Changes - about 1 year ago Neurofilament Light Predicts MS Worsening in Silent Progression - over 1 year ago
2	Nicole Lou MedPage Today Medical reporter @medpagetoday. Bird advocate. undisclosed remote location medical reporting	Aortic Stenosis Outcomes Worsen With Cardiac Amyloidosis Also in the Picture - 6 days ago
3	Jason Mast STAT News Writing about science, medicine. ScienceMedicineBusiness	STAT+: Google’s secretive anti-aging company Calico finally released data. Its drug failed - 15 days ago STAT+: Avidity Biosciences says its experimental drug showed potential against form of muscular dystrophy - 7 months ago STAT+: They carry a gene for ALS but aren’t sick. What does medical research owe them? - over 1 year ago
4	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	STAT+: Axsome to send Alzheimer’s disease drug to FDA, despite mixed Phase 3 results - 23 days ago
5	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Leriglitazone meets endpoint in trial for cerebral adrenoleukodystrophy - about 1 month ago
6	Emily Hutto MedPage Today Video Producer, MedPageToday. New York City video productionpodcasting	Three Important Changes in AASM's New Restless Legs Syndrome Guidelines - 2 months ago
7	Shelby Bradford, PhD The Scientist Assistant Editor @TheScientistLLC. Opinions my own. scienceediting	Sleep Disruptions and Impaired Muscle Control in Ataxia May Share a Culprit - 3 months ago
8	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	A setback for the tau approach to Alzheimer’s - 3 months ago
9	David Nield Science Alert Freelance tech, science writer. Marple, Manchester, UK Technologysciencewriting	Alzheimer's Disease Harms The Brain in 2 Distinct Phases, Study Reveals - 3 months ago Hoarding Junk Proteins Could Increase Our Risk of ALS - 10 months ago Blocking a Single Protein Could Prevent Nerve Damage Responsible For Alzheimer's - 11 months ago
10	Sophie Putka MedPage Today Enterprise, investigative writer. New York, USA enterprise journalisminvestigative journalism	A Miss for Steroid-Toting Red Blood Cells in Ataxia Telangiectasia - 5 months ago Obesity Associated With Faster MS Disease Progression - 11 months ago

Journalists covering amyotrophic lateral sclerosis